12:09 PM EST - Clearmind Medicine : Will host a virtual investor conference titled “Psychedelics for Obesity” on Monday, June 12th, at 10:00 AM EST. Clearmind recently announced positive pre-clinical results demonstrating efficacy of its drug candidate MEAI for treating obesity and metabolic syndrome. Clearmind Medicine
shares C.CMND are trading unchanged at $0.71.
